Morgan Stanley’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $317M | Sell |
|
|||||
|
2021
Q1 | $275M | Buy |
|
|||||
|
2020
Q4 | $176M | Buy |
|
|||||
|
2020
Q3 | $74M | Buy |
|
|||||
|
2020
Q2 | $58.8M | Sell |
|
|||||
|
2020
Q1 | $56.6M | Sell |
|
|||||
|
2019
Q4 | $107M | Buy |
|
|||||
|
2019
Q3 | $56.9M | Sell |
|
|||||
|
2019
Q2 | $84.3M | Buy |
|
|||||
|
2019
Q1 | $81.1M | Sell |
|
|||||
|
2018
Q4 | $76.9M | Buy |
|
|||||
|
2018
Q3 | $109M | Buy |
|
|||||
|
2018
Q2 | $95.1M | Sell |
|
|||||
|
2018
Q1 | $113M | Buy |
|
|||||
|
2017
Q4 | $88.5M | Sell |
|
|||||
|
2017
Q3 | $129M | Buy |
|
|||||
|
2017
Q2 | $95.5M | Buy |
|
|||||
|
2017
Q1 | $71M | Buy |
|
|||||
|
2016
Q4 | $33.8M | Sell |
|
|||||
|
2016
Q3 | $55.7M | Sell |
|
|||||
|
2016
Q2 | $79.5M | Buy |
|
|||||
|
2016
Q1 | $20.4M | Sell |
|
|||||
|
2015
Q4 | $52.5M | Sell |
|
|||||
|
2015
Q3 | $105M | Buy |
|
|||||
|
2015
Q2 | $79.2M | Sell |
|
|||||
|
2015
Q1 | $112M | Sell |
|
|||||
|
2014
Q4 | $168M | Buy |
|
|||||
|
2014
Q3 | $120M | Sell |
|
|||||
|
2014
Q2 | $126M | Buy |
|
|||||
|
2014
Q1 | $109M | Buy |
|
|||||
|
2013
Q4 | $48.8M | Buy |
|
|||||
|
2013
Q3 | $28.3M | Sell |
|
|||||
|
2013
Q2 | $27.6M | Buy |
|